A Phase I Study of Immune Gene Therapy for Patients With CLL Using a Membrane-Stable, Humanized CD154

Leukemia - United Kingdom
doi 10.1038/leu.2010.191
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Gene Immunotherapy of Chronic Lymphocytic Leukemia: A Phase I Study of Intranodally Injected Adenovirus Expressing a Chimeric CD154 Molecule

Cancer Research
Cancer ResearchOncology
2012English

Clinical Benefit of Antisense Therapy in a Phase III Trial in Patients With CLL

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2007English

A Phase I Study of Farletuzumab, a Humanized Anti-Folate Receptor Α Monoclonal Antibody, in Patients With Solid Tumors

Investigational New Drugs
OncologyPharmacology
2014English

Gene Therapy for Pain: Results of a Phase I Clinical Trial

Annals of Neurology
Neurology
2011English

A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2010English

Venetoclax: Another Oral Therapy Option for Patients With CLL

Pharmacy Today
2016English

First-In-Man Phase I Study of GC33, a Novel Recombinant Humanized Antibody Against Glypican-3, in Patients With Advanced Hepatocellular Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2013English

A Phase II Trial of Eltrombopag for Patients With Chronic Lymphocytic Leukaemia (CLL) and Thrombocytopenia

British Journal of Haematology
Hematology
2018English

A Phase I Clinical Trial for [131I]meta-Iodobenzylguanidine Therapy in Patients With Refractory Pheochromocytoma and Paraganglioma: A Study Protocol

Journal of Medical Investigation
BiochemistryMedicineGeneticsMolecular Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy